Bernstein Upgrades Biogen (BIIB) to Outperform
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $220.53 -1.77%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Bernstein upgraded Biogen (NASDAQ: BIIB) from Market Perform to Outperform with a price target of $385.00 (from $436.00).
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $300.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Raised to $245 at Piper Sandler
- Hello Group (MOMO) PT Lowered to $8 at StoneX, Buy Rating Maintained
- Six Flags Entertainment (FUN) PT Lowered to $27 at UBS, Estimates Revised
Create E-mail Alert Related Categories
Analyst PT Change, Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
